Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 31;71(11):2933-2938.
doi: 10.1093/cid/ciaa880.

Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City

Keith Sigel  1 , Talia Swartz  2 , Eddye Golden  3 , Ishan Paranjpe  3   4 , Sulaiman Somani  3   4 , Felix Richter  3   4 , Jessica K De Freitas  3   4 , Riccardo Miotto  3   4 , Shan Zhao  3   5 , Paz Polak  6 , Tinaye Mutetwa  1 , Stephanie Factor  2 , Saurabh Mehandru  7 , Michael Mullen  2 , Francesca Cossarini  2 , Erwin Bottinger  3   8 , Zahi Fayad  9   10 , Miriam Merad  6   11   12 , Sacha Gnjatic  6   11   12 , Judith Aberg  2 , Alexander Charney  4   13   14 , Girish Nadkarni  3   11   15 , Benjamin S Glicksberg  3   4
Affiliations

Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City

Keith Sigel et al. Clin Infect Dis. .

Abstract

Background: There are limited data regarding the clinical impact of coronavirus disease 2019 (COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we compared outcomes for PLWH with COVID-19 to a matched comparison group.

Methods: We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our hospital system in New York City between 12 March and 23 April 2020. We collected data on baseline clinical characteristics, laboratory values, HIV status, treatment, and outcomes from this group and matched comparators (1 PLWH to up to 5 patients by age, sex, race/ethnicity, and calendar week of infection). We compared clinical characteristics and outcomes (death, mechanical ventilation, hospital discharge) for these groups, as well as cumulative incidence of death by HIV status.

Results: Patients did not differ significantly by HIV status by age, sex, or race/ethnicity due to the matching algorithm. PLWH hospitalized with COVID-19 had high proportions of HIV virologic control on antiretroviral therapy. PLWH had greater proportions of smoking (P < .001) and comorbid illness than uninfected comparators. There was no difference in COVID-19 severity on admission by HIV status (P = .15). Poor outcomes for hospitalized PLWH were frequent but similar to proportions in comparators; 18% required mechanical ventilation and 21% died during follow-up (compared with 23% and 20%, respectively). There was similar cumulative incidence of death over time by HIV status (P = .94).

Conclusions: We found no differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demographically similar patient group.

Keywords: coronavirus 2019; human immunodeficiency virus; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Major outcomes for people living with HIV and matched comparators hospitalized in New York City with coronavirus 2019. (*Composite outcome including death, intensive care unit admission, or mechanical ventilation. **Mutually exclusive categorical outcomes). Abbreviation: HIV, human immunodeficiency virus.
Figure 2.
Figure 2.
Cumulative incidence of death comparing people living with HIV to matched uninfected comparators during the coronavirus 2019 pandemic, March 2020–April 2020, in New York City. Abbreviation: HIV, human immunodeficiency virus.
See this image and copyright information in PMC

Comment in

References

    1. COVID-19 Projections. Available at: https://covid19.healthdata.org/united-states-of-america/new-york. Accessed 7 May 2020.
    1. Giroir BP. The time is now to end the HIV epidemic. Am J Public Health 2020; 110:22–4. - PMC - PubMed
    1. So-Armah KA, Tate JP, Chang CH, et al. ; VACS Project Team Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people? J Acquir Immune Defic Syndr 2016; 72:206–13. - PMC - PubMed
    1. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020; 20:363–74. - PMC - PubMed
    1. Justice AC, Dombrowski E, Conigliaro J, et al. . Veterans Aging Cohort Study (VACS): overview and description. Med Care 2006; 44:S13–24. - PMC - PubMed

Publication types